Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intracoronary epinephrine versus adenosine for slow/no-reflow during primary PCI in STEMI
IRCT20120215009014N566Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Aug 2025
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in myocardial infarction (MI) comparing Intracoronary epinephrine with Intracoronary adenosine (2 arms). Primary endpoint: Myocardial blood flow. Started Aug 2025; status: completed.
02
Drugs
epinephrineadenosine
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on IRCT20120215009014N566.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N566.